Last reviewed · How we verify
Sci-B-Vac Hepatitis B Vaccine
Sci-B-Vac Hepatitis B Vaccine is a Biologic drug developed by Tel-Aviv Sourasky Medical Center. It is currently in Phase 3 development for Prevention of hepatitis B infection.
Sci-B-Vac Hepatitis B Vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus.
Sci-B-Vac Hepatitis B Vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus. Used for Prevention of hepatitis B infection.
At a glance
| Generic name | Sci-B-Vac Hepatitis B Vaccine |
|---|---|
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
This vaccine contains inactivated hepatitis B virus particles that are used to stimulate the body's immune system to produce antibodies against the virus. The immune system then remembers how to fight the virus, providing long-term protection against infection.
Approved indications
- Prevention of hepatitis B infection
Common side effects
- Injection site pain
- Fatigue
- Headache
Key clinical trials
- A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults (PHASE3)
- Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B® (PHASE3)
- A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™ (PHASE4)
- Lot-to-lot Consistency of Sci-B-Vac™ in Adults (PHASE3)
- Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults (PHASE3)
- Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease (NA)
- ID HBV Vaccination With Imiquimod in OBI (PHASE2, PHASE3)
- Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sci-B-Vac Hepatitis B Vaccine CI brief — competitive landscape report
- Sci-B-Vac Hepatitis B Vaccine updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI
Frequently asked questions about Sci-B-Vac Hepatitis B Vaccine
What is Sci-B-Vac Hepatitis B Vaccine?
How does Sci-B-Vac Hepatitis B Vaccine work?
What is Sci-B-Vac Hepatitis B Vaccine used for?
Who makes Sci-B-Vac Hepatitis B Vaccine?
What development phase is Sci-B-Vac Hepatitis B Vaccine in?
What are the side effects of Sci-B-Vac Hepatitis B Vaccine?
Related
- Manufacturer: Tel-Aviv Sourasky Medical Center — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of hepatitis B infection
- Compare: Sci-B-Vac Hepatitis B Vaccine vs similar drugs
- Pricing: Sci-B-Vac Hepatitis B Vaccine cost, discount & access